elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26745532-29D6D7D9-5E28-44C6-ABA8-2F5AF60DC28D
Q26745532-29D6D7D9-5E28-44C6-ABA8-2F5AF60DC28D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745532-29D6D7D9-5E28-44C6-ABA8-2F5AF60DC28D
Ribosomal Antibiotics: Contemporary Challenges
P2860
Q26745532-29D6D7D9-5E28-44C6-ABA8-2F5AF60DC28D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745532-29D6D7D9-5E28-44C6-ABA8-2F5AF60DC28D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
847e321138f57ad5d8391a8024553a0bef532d41
P2860
Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis